BANK OF AMERICA CORP /DE/ - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 29 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q4 2022$20
-98.0%
9
-98.4%
0.00%
Q2 2022$1,000579
+456.7%
0.00%
Q1 2022$0104
-16.1%
0.00%
Q4 2021$0124
+19.2%
0.00%
Q3 2021$0104
-41.6%
0.00%
Q2 2021$0
-100.0%
178
-93.5%
0.00%
Q1 2021$8,000
+33.3%
2,748
+56.6%
0.00%
Q2 2020$6,000
+500.0%
1,755
+1039.6%
0.00%
Q4 2019$1,000
-66.7%
154
-67.2%
0.00%
Q3 2019$3,000470
+1520.7%
0.00%
Q4 2018$0
-100.0%
29
-95.6%
0.00%
Q3 2018$4,000657
+7200.0%
0.00%
Q2 2018$0
-100.0%
9
-89.9%
0.00%
Q3 2017$1,00089
+4350.0%
0.00%
Q4 2016$02
-95.9%
0.00%
Q2 2016$049
-44.3%
0.00%
Q3 2014$088
+340.0%
0.00%
Q4 2013$0
-100.0%
20
-97.8%
0.00%
Q3 2013$4,000
-97.1%
900
-96.6%
0.00%
Q2 2013$136,00026,5490.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q1 2022
NameSharesValueWeighting ↓
Sterling Financial Planning, Inc. 22,031$46,0000.03%
BERKSHIRE ASSET MANAGEMENT LLC/PA 189,048$392,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 286,655$595,0000.01%
Renaissance Technologies 622,228$1,291,0000.00%
ACADIAN ASSET MANAGEMENT LLC 188,164$390,0000.00%
Oakworth Capital, Inc. 3,052$6,0000.00%
BlackRock Inc. 140,248$292,0000.00%
Citadel Advisors 32,300$67,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 28,900$60,0000.00%
TWO SIGMA ADVISERS, LP 34,592$72,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders